**Author details**

Larisa Dmitrievna Belotserkovtseva\* and Yulia Igorevna Mayer Surgut Clinical Perinatal Center, Surgut State University, KhMAO-Ugra, Russia

\*Address all correspondence to: mayerjul@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**17**

*The Importance of the Problem of HPV-Associated Diseases in KhMAO-Ugra: Vaccination…*

tactics of management. Gynecology.

[10] The State of Cancer Care to the Population of Khanty-Mansiysk Autonomous Region -Ugra in 2018. Khanty-Mansiysk: Medical Information and Analytical Center. 2018. Available from: https://www.dzhmao.ru/ company/zdorove-v-tsifrakh/ pokazateli-zabolevaemosti.php

[11] Evstigneeva NP. Expression of oncoprotein E7 in patients with urogenital papillomavirus infection. Russian Journal of Skin and Venereal

[12] Kondrikov NI. Others the importance of immunohistochemical determination of biomarkers of squamous epithelial lesions of the cervix. Obstetrics and

Diseases. 2006;**2**:4-6

Gynecology. 2010;**6**:44-48

[13] Belotserkovtseva LD et al.

[14] Kumykova ZH. Human

2015;**3**:9-18

2014. p. 364

2015. p. 14

Reproductive behavior of adolescents and experience in prevention of HPVassociated diseases in KHMAO-Ugra. Questions of Gynecology, Obstetrics and Perinatology. 2018;**17**(1):100-108

papillomavirus vaccines: Analysis of efficacy and safety of use. Reproductive Health of Children and Adolescents.

[15] The Integrated Fight against

[16] Federal Clinical Guidelines for the Management of Patients with Anogenital (Venereal) Warts. Moscow;

[17] Vaccination of diseases caused by human papilloma virus: Federal Clinical Recommendations of the Ministry of Health of the Russian Federation,

Cervical Cancer. Clinical Guideline. 2nd ed. Geneva: World health organisation;

2018;**20**(3):5-11

*DOI: http://dx.doi.org/10.5772/intechopen.90668*

[1] The WHO Position Paper on Vaccines against Human Papillomavirus (HPV). 2009. Available from: http://www.who. int/immunization/documents/HPV\_ position\_paper\_summary.pdf?ua=1

[2] Human Papillomavirus and Related Diseases Report/World/Version. 2014. Available from: www.hpvcenter.net

[3] Munoz N, et al. HPV in the Etiology of Human Cancer. Vaccine 24S3. 2006.

[4] Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative

[5] GLOBOCAN. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in World. Summary. Available from: www.who.int/hpvcentre

[Accessed: September 09, 2012]

[6] Kostin AA. Analysis of statistical data on malignant neoplasms associated with human papilloma virus. Research and Practical Medicine Journal.

[7] Gretsova OP, Kostin AA, et al. Morbidity and mortality from malignant neoplasms associated with human papilloma virus. Research and Practical Medicine Journal.

[8] Kaprin AD, et al. The State of Cancer Care in Russia in 2018. Moscow. 2019. Available from: http://www.oncology. ru/service/statistics/condition/2018.pdf

[9] Tikhomirov AL et al. Human papilloma virus: From understanding of immunopathogenesis to rational

treatment for intraepithelial or early invasive cervical lesions: Systematic review and meta-analysis. Lancet.

**References**

S3/1–S3/10

2006;**367**:489-498

2016;**3**:66-78

2017;**4**(3):33-50

*The Importance of the Problem of HPV-Associated Diseases in KhMAO-Ugra: Vaccination… DOI: http://dx.doi.org/10.5772/intechopen.90668*
